AI-READI study will collect and release a flagship medical dataset intended to accelerate machine learning applications and generate novel hypotheses about Type 2 Diabetes Mellitus.
Innovative and continuous remote patient monitoring, along with AI-based predictive analytics, are advancing progress toward replacing the one-size-fits-all, population-driven vaccination model.